PARIS, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced today that it has expanded its existing partnership with Institute of Isotopes Co. Ltd. (Izotop) to make ...

PARIS, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced today that it has expanded its existing partnership with Institute of Isotopes Co. Ltd. (Izotop ...

Curium, a world leader in nuclear medicine, announced that Pylclari is now available for patients with prostate cancer in Estonia, Finland, Latvia, and Sweden. Pylclari (INN: Piflufolastat (18F) also ...

PARIS, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, today announced that in Estonia, Finland, Latvia, and Sweden, PYLCLARI® is now available for patients with ...

PYLCLARI ® is being produced by Curium at its facilities in Helsinki, Finland – ensuring distribution to Estonia, Finland, Latvia, and Sweden. For more information about PYLCLARI ®: www.pylclari.com ...

Find out more about how we test. With the NordPass password generator, you can quickly create new passwords both online and within the NordPass password management app. It supports the generation ...

Shield AI's Hivemind software, which enables autonomous drone operations in GPS-denied environments, is its key appeal. Contracts with the Ukrainian government and the U.S. military have further ...

Our editors also may be in touch with follow-up questions. American Home Shield has been offering comprehensive home warranty plans since 1971 and is on our list of best home warranty companies ...

If you’re thinking about dropping big money on a solar generator, consider shopping on big shopping holidays like Amazon Prime Day or Black Friday. These are expensive devices and they ...

The agreement also includes a strategic contract manufacturing agreement appointing Curium as the manufacturer of the product for Telix. Kevin Richardson, Chief Executive Officer, Telix Precision ...

MELBOURNE, Australia and LIÈGE, Belgium, Jan. 13, 2025 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) today announces that it has entered into an agreement ...